View more on these topics

Product matters

Even though death is a certainty, we are all going to spend lots of money to guard against it.

Sarasin has so far been known primarily for its EquiSar fund range, the pioneer of thematic funds before they became fashionable. It is now launching the global health fund under the stewardship of Dr Irene Puttner and her experienced team.

Sarasin itself has a long association with the pharmaceutical industry.

Nothing touches our lives quite so poignantly as health. The impact of the genomic revolution, technological advances and ground-breaking research will lead to exciting opportunities in the fields of prevention and cure against a background of a rapidly ageing population.

In 20 years time,20-25 per cent of the population of industrialised nations will be over 65. That has got to benefit our industry.

Sarasin&#39s fund will opt for around 40 per cent in pharmaceutical companies, 30 per cent in the medical technology field and the rest in biotechnology. It will have some 65 holdings, inevitably with a major emphasis on America, incorporating Sarasin&#39s thematic top-down appraisal of key trends.

It has produced a first-class brochure outlining the enormous potential in this sector. It is important to compare the fund with others, such as Schroder medical discovery, Franklin, Framlington, Britannic and First State, to name a few.

As part of a global growth portfolio, healthcare-type funds can offer significant potential, admittedly often at higher risk and Sarasin deserves to be considered alongside the established players.

Michael Owen is joint managing director of Plan Invest Group

Recommended

Protection from the cold

ALIGN=”JUSTIFY”>Luxury may describe a lead crystal flute of the finest champagne, a Rolex watch or simply a long soak in a hot bath. But, where there is no job to go to, homeowners may face the prospect of having no roof over their heads, let alone a bath to relax in, if they cannot meet […]

Newton fund manager in car crash

Newton Income fund manager Robert Shelton was seriously ill in hospital this week, following a car crash on Friday. In a statement issued on Tuesday, Newton said: “We are all hoping that Robert makes a full and speedy recovery and obviously our thoughts are with him and his family at this time.”

Heath warns of multi-ties orphaning millions

Former head of the IFA Association Garry Heath is warning that millions of consumers will be “orphaned” because of an advice black hole if IFAs are forced to multi-tie with the scrapping of polarisation.Heath, speaking out for the first time since leaving IFA support group PMS and becoming Impartial financial consultancy chairman, warns that the […]

Tracking the top companies

iShares, an arm of Barclays Global Investors, has brought out the iShares FTSE Eurotop 100 exchange-traded fund. This brings the number of ETFs in their range up to 12.It gives investors the chance to track the FTSE Eurotop 100 index, the largest 100 companies in Europe including the UK. The index is made up of […]

Thumbnail

Case study: administration — implementing a management log

Our client is a leading video game and publishing company best known for its console role-playing game franchises. The client provides a number of benefits, at varying levels and cost that attract a P11d liability. With the absence of a management log to track data for benefit movements, enormous administrative and therefore cost implications were occurring each year just to comply with P11d reporting requirements.

Newsletter

News and expert analysis straight to your inbox

Sign up

Comments

    Leave a comment